The Trump administration is requesting more than $1.4 billion in new funds from Congress to address the escalating Ebola virus outbreak. The supplemental funding request, outlined in a letter to Congress on Wednesday, includes $800 million designated for humanitarian crisis response.
This humanitarian funding is intended for a quarantine center in Kenya for Americans exposed to the virus, as well as for supplies, treatment, contact tracing, a regional logistics network, and infection-control practices. An additional $500 million is sought for global health security initiatives aimed at preventing the virus's spread to the United States. These funds would support disease surveillance, laboratory capacity, cross-border coordination, and potential partnerships with multilateral organizations and the private sector. The request also includes $90 million for diplomatic efforts, such as the evacuation and transportation of U.S. citizens diagnosed with the virus to treatment facilities.
The Democratic Republic of Congo is currently experiencing an outbreak linked to the rare Bundibugyo strain of the virus, which has infected over 1,000 people and resulted in 267 deaths. According to the World Health Organization, this outbreak has generated the largest number of confirmed cases within the first month of any recorded Ebola episode. Major previous outbreaks occurred in West Africa between 2014 and 2016, and in Congo from 2018 to 2020.
This significant funding request faces potential challenges in Congress. Some lawmakers, including Republicans, have expressed dissatisfaction with the administration's withholding of previously allocated foreign assistance funds. Critics have pointed to cuts in the U.S. Agency for International Development and African public health programs as potentially hindering the current response.
Previously, the U.S. Centers for Disease Control and Prevention announced on June 18 that it would provide $107 million in emergency funding to bolster both domestic and international response efforts, warning that the outbreak could be the most severe yet. The U.S. has also supplied doses of an experimental antibody drug for clinical trials to combat the outbreak, a change from its prior policy of reserving the drug for Americans. A doctor in France who had recently returned from a humanitarian mission in the Democratic Republic of Congo has tested positive for Ebola, marking Europe's first confirmed case linked to this outbreak. World Health Organization Chief Tedros Adhanom Ghebreyesus stated that the risk of further spread of the virus is currently low.